Pierre Gros
27Patents
9h-index
14Co-inventors
72Inventor score
Filing activity: Jun 16, 1978 → May 6, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4414148A | Anti-cancer drugs for the treatment of melanomas and method for preparing thereof | Emerging Cross-Sectional Technologies | 170 | Expired |
| US4686653A | Method and device for making geophysical measurements within a wellbore | Physics | 113 | Expired |
| US4340535A | Cytotoxic products formed by covalent bonding of the A chain of ricin with an antibody and the process for their preparation and use | Emerging Cross-Sectional Technologies | 80 | Expired |
| US4980457A | Cytotoxic conjugates which can be used in therapy and process for their preparation | Human Necessities | 34 | Expired |
| US4718048A | Method of instantaneous acoustic logging within a wellbore | Physics | 29 | Expired |
| US4762707A | New conjugates associating, by covalent bond, an enzyme with an antibody, and medicinal associations using the said conjugates | Chemistry; Metallurgy | 22 | Expired |
| US4670862A | Apparatus for producing geophysical measurements in a borehole | Emerging Cross-Sectional Technologies | 17 | Expired |
| US4811814A | Measuring device for a seismic profile within a well-bore | Emerging Cross-Sectional Technologies | 14 | Expired |
| US4690906A | Nephelometric determination of HB.sub.s antigen with antibody-containing microparticles | Emerging Cross-Sectional Technologies | 9 | Expired |
| US4856614A | Process and device for seismic prospecting of a medium with induced waves created artificially in a bore-hole | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4749566A | Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer | Emerging Cross-Sectional Technologies | 6 | Expired |
| US4670563A | Imidazolides as intermediates for the synthesis of cytotoxic conjugates | Human Necessities | 6 | Expired |
| US4293935A | Method of seismic exploration | Physics | 6 | Expired |
| US4906469A | Appropriate cytotoxic pharmaceutical combination especially for the treatment of cancers | Emerging Cross-Sectional Technologies | 5 | Expired |
| US4643895A | Anti-cancer drugs for the treatment of leukaemias I, constituted by the chain A of ricin and a specific monoclanal antibody | Emerging Cross-Sectional Technologies | 5 | Expired |
| US4582703A | Cytotoxic medicament formed from the association of at least one immunotoxin and chloroquin | Human Necessities | 4 | Expired |
| US4767621A | Drugs comprising in association at least one immunotoxin and at least one monovalent carboxylic ionophore | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8234344B2 | Providing analytical view of email information | Physics | 4 | Active |
| US4897398A | Hydrochlorides of chlorides of 2-aminoalkyl-9-hydroxy-ellipticinium derivatives and pharmaceutical compositions containing them | Human Necessities | 4 | Expired |
| US4919928A | Conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, their use as immunotoxin potentiators and the intermediate activated ionophores | Chemistry; Metallurgy | 3 | Expired |
| US4614650A | Cytotoxic composition including at least an immunotoxine and an amine | Human Necessities | 3 | Expired |
| US4775960A | Method and device for measuring vibrational stresses and velocities of waves propagated within formations surrounding a wellbore | Physics | 3 | Expired |
| US5185434A | Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units | Human Necessities | 1 | Expired |
| US5144009A | Conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, their use as immunotoxin potentiators and the intermediate activated inophores | Chemistry; Metallurgy | 0 | Expired |
| US8386474B2 | Generation of query language parameter file | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.